Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

pcDNA3.2 TDP-43 5F-L YFP Citations (3)

Originally described in: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rub U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD Nature. 2010 Aug 26;466(7310):1069-75. doi: 10.1038/nature09320.
PubMed Journal

Articles Citing pcDNA3.2 TDP-43 5F-L YFP

Articles
TDP-43 misexpression causes defects in dendritic growth. Herzog JJ, Deshpande M, Shapiro L, Rodal AA, Paradis S. Sci Rep. 2017 Nov 15;7(1):15656. doi: 10.1038/s41598-017-15914-4. PubMed
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ, Guo L, Calder CB, Wills ZP, Pandey UB, Kofler JK, Brodsky JL, Thathiah A, Shorter J, Donnelly CJ. Neuron. 2019 Feb 27. pii: S0896-6273(19)30075-3. doi: 10.1016/j.neuron.2019.01.048. PubMed
Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export. Duan L, Zaepfel BL, Aksenova V, Dasso M, Rothstein JD, Kalab P, Hayes LR. Cell Rep. 2022 Jul 19;40(3):111106. doi: 10.1016/j.celrep.2022.111106. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.